4 ms·
The profit motive would clearly prioritize finding an expensive medication that must be taken regularly and indefinitely. Psychedelic research up to now is poin
by SuoDuanDao 6y ago
The profit motive would clearly prioritize finding an expensive medication that must be taken regularly and indefinitely. Psychedelic research up to now is pointing to small numbers of uses having lasting positive effects. There is a fear that research driven by a profit motive will try to not just not investigate this further but actively gloss over this potential medicine.
- PragmaticPulp 6y ago> The profit motive would clearly prioritize finding an expensive medication that must be taken regularly and indefinitely. The idea that pharmaceutical companies are deliberately avoiding one-time treatments is a myth. If you assume profit is the ultimate motive, there's nothing stopping a pharmaceutical company from charging $10,000 for a long-lasting depression treatment. It's not like pharmaceutical companies are going to stumble upon a perfect treatment and then decline to patent it. Also, patents don't last forever. Common SSRI anti-depressants are available for $4-5/month.